Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
Clin Res Hepatol Gastroenterol
    September 2022
  1. COILLY A, Sebagh M, Fougerou-Leurent C, Pageaux GP, et al
    HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Sep 16:102024.
    >> Share

    August 2022
  2. OKUMURA T, Joshita S, Sugiura A, Ota M, et al
    Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals.
    Clin Res Hepatol Gastroenterol. 2022 Aug 25:102011.
    >> Share

  3. YANG X, Wang N, Li S, Gu Y, et al
    No differences in the risk of Hepatocellular Carcinoma from Using Direct-Acting Antiviral Agents or Interferon in Patients with Chronic Hepatitis C: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022 Aug 12:102001.
    >> Share

  4. CAROLE S, Elena L, Benedicte LV, Abdoul-Aziz D, et al
    Acute Myeloid Leukaemia following Direct Acting Antiviral drugs in HCV-infected patients: a 10 years' retrospective single-center study.
    Clin Res Hepatol Gastroenterol. 2022 Aug 3:102000.
    >> Share

    May 2022
  5. DE CONTO F, Buttrini M, Dell'Anna ML, Maccari C, et al
    Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital.
    Clin Res Hepatol Gastroenterol. 2022;46:101892.
    >> Share

    April 2022
  6. AZZI J, Dorival C, Cagnot C, Fontaine H, et al
    Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
    Clin Res Hepatol Gastroenterol. 2022 Apr 8:101923.
    >> Share

    January 2022
  7. KHALID SS, Abdo AA, Al-Hamoudi W, Alswat K, et al
    Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients.
    Clin Res Hepatol Gastroenterol. 2022 Jan 6:101860.
    >> Share

    December 2021
  8. COLUCCI G, Renteria SU, Lunghi G, Ceriotti F, et al
    Italian Migrants Study: an HCV and HBV Micro-Elimination Pilot Project.
    Clin Res Hepatol Gastroenterol. 2021 Dec 16:101852.
    >> Share

    September 2021
  9. CLEMENTE MG, Mauceri C, Grandi N, Marescalco S, et al
    No Hepatitis G virus co-infection in migrants with Hepatitis B or C hosted in Sardinia and Sicily.
    Clin Res Hepatol Gastroenterol. 2021;45:101566.
    >> Share

  10. GEROSSIER L, Dubois A, Paturel A, Fares N, et al
    PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?
    Clin Res Hepatol Gastroenterol. 2021;45:101553.
    >> Share

    July 2021
  11. TRAN A, Shili-Masmoudi S, Moga L, Chevaliez S, et al
    NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101771.
    >> Share

    June 2021
  12. EL-BARAKY IA, Abbassi MM, Ebied FS, Hassany M, et al
    Beta-Thalassemia Major alters Sofosbuvir/Ledipasvir exposure in Hepatitis-C virus Infected Adolescent Patients.
    Clin Res Hepatol Gastroenterol. 2021 Jun 26:101747.
    >> Share

    May 2021
  13. SHIHA G, Soliman R, Mikhail N, Zaky S, et al
    HCC developed in CHC patients who achieved SVR following DAAs tend to display less aggressive pattern.
    Clin Res Hepatol Gastroenterol. 2021;45:101608.
    >> Share

    April 2021
  14. NABATCHIKOVA EA, Abdurakhmanov DT, Rozina TP, Nikulkina EN, et al
    Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101714.
    >> Share

  15. TREPO C
    THE 2020 NOBEL PRIZE OF MEDICINE FOR THREE HEPATITIS C DISCOVERY PIONEERS : A MEDICAL HISTORY MILESTONE.
    Clin Res Hepatol Gastroenterol. 2021 Apr 10:101689.
    >> Share

    March 2021
  16. AL-KHAYKANEE AM, Abdel-Rahman AA, Essa A, Gadallah AA, et al
    Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2021;45:101636.
    >> Share

  17. LAZARUS JV, Picchio CA, Guy D, Aleman S, et al
    Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
    Clin Res Hepatol Gastroenterol. 2021;45:101564.
    >> Share

    February 2021
  18. ROGER S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, et al
    HCV virology and diagnosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101626.
    >> Share

  19. ROUDOT-THORAVAL F
    Epidemiology of hepatitis C virus infection.
    Clin Res Hepatol Gastroenterol. 2021;45:101596.
    >> Share

    November 2020
  20. PARLATI L, Hollande C, Pol S
    Treatment of hepatitis C virus infection.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101578.
    >> Share

  21. BOLETO G, Vieira M, Saadoun D, Cacoub P, et al
    Hepatitis C virus-related vasculitis.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101575.
    >> Share

    September 2020
  22. MONTASSER IF, Ibrahim AA, Farid HM, Al Balakosy AM, et al
    De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?
    Clin Res Hepatol Gastroenterol. 2020 Sep 5. pii: S2210-7401(20)30212.
    >> Share

    July 2020
  23. EL-FATTAH MA
    Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2020 Jul 1. pii: S2210-7401(20)30175.
    >> Share

    June 2020
  24. VALLET-PICHARD A, Correas JM, Dorival C, Zoulim F, et al
    Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
    Clin Res Hepatol Gastroenterol. 2020 Jun 25. pii: S2210-7401(20)30152.
    >> Share

    December 2019
  25. ZARSKI JP, David-Tchouda S, Trocme C, Margier J, et al
    Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016